Influence of the administration of human annexin V on in vitro binding of small hepatitis B surface antigen to human and to rat hepatocytes and on in vitro hepatitis B virus infection

Journal of Viral Hepatitis

Volumn 7, Issue 2, 2000, Pages 104-114

  De Meyer, S ^d   Gong, Z J ^d   Hertogs, K ^b   Depla, E ^a   Van Pelt, J F ^d   Roskams, T ^d   Maertens, G ^a   Yap, H S ^c  

^a INNOGENETICS   (Belgium)

^b Virco BVBA   (Belgium)

^c UNIVERSITY HOSPITALS LEUVEN   (Belgium)

^d NONE

Author keywords

Hepatocytes; Human annexin V; In vitro HBV infection

Indexed keywords

CIRCULAR DNA; HEPATITIS B CORE ANTIGEN; HEPATITIS B SURFACE ANTIGEN; LIPOCORTIN 5; MESSENGER RNA; VIRUS DNA;

ANIMAL CELL; ANTIGEN BINDING; ARTICLE; GENE EXPRESSION; HEPATITIS B; HUMAN; HUMAN CELL; IMMUNOCYTOCHEMISTRY; INFECTION SENSITIVITY; LIVER CELL; NONHUMAN; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; RAT; SOUTHERN BLOTTING;

ANIMALS; ANNEXIN A5; CELLS, CULTURED; CRYOPRESERVATION; DISEASE SUSCEPTIBILITY; HEPATITIS B; HEPATITIS B SURFACE ANTIGENS; HEPATITIS B VIRUS; HUMANS; LIVER; PROTEIN BINDING; RATS; RATS, WISTAR;

EID: 0034108570     PISSN: 13520504     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2893.2000.00207.x     Document Type: Article

References (57)

1. 1 Robinson WS, Marion PL, Feitelson M, Siddiqui A. The hepadnavirus group: hepatitis B and related viruses. In: Szmuness W, Alter HJ. Maynard JE. eds. Viral Hepatitis -1981 International Symposium. Philadelphia: Franklin Institute Press, 1982: 57-68.
2. 2 Walter E, Keist R, Niederost B, Pult I, Blum HE. Hepatitis B virus infection of tupaia hepatocytes in vitro and in vivo. Hepatology 1996; 24: 1-5.
3. 3 Shih CH, Li LS, Roychoudhury S, Ho MH. In vitro propagation of human hepatitis B virus in a rat hepatoma cell line. Proc Natl Acad Sci USA 1989; 86: 6323-6327.
4. 4 Takahashi H, Fujimoto J, Hanada S, Isselbacher KJ. Acute hepatitis in rats expressing human hepatitis B virus transgene. Proc Natl Acad Sci USA 1995; 92: 1470-1474.
5. 5 Farza H, Hadchouel M, Scotto J, Tiollais P, Babinet C, Pourcel C. Replication and gene expression of hepatitis B virus in a transgenic mouse that contains the complete viral genome. J Virol 1988; 62: 4144-4152.
6. 6 Guidotti LG, Matzke B, Schaller H, Chisari FV. High-level hepatitis B virus replication in transgenic mice. J Virol 1995; 69: 6158-6169.
7. 7 Imai M, Yanase Y, Nojiri T, Miyakawa Y, Mayumi M. A receptor for polymerized human and chimpanzee albumins on hepatitis B virus particles co-occurring with HBeAg. Gastroenterology 1979; 76: 242-247.
8. 8 Trevisan A, Gudat F, Guggenheim R et al. Demonstration of albumin receptors on isolated human hepatocytes by light and scanning electron microscopy. Hepatology 1982; 2: 832-835.
9. 9 Machida A, Kishimoto S, Ohnuma H et al. A hepatitis B surface antigen polypeptide (P31) with the receptor for polymerized human as well as chimpanzee albumins. Gastroenterology 1983; 85: 268-274.
10. 10 Ishihara K, Waters JA, Pignatelli M, Thomas HC. Characterisation of the polymerised and monomeric human serum albumin binding sites on hepatitis B surface antigen. J Med Virol 1987; 21: 89-95.
11. 11 Neurath AR, Kent SB, Parker K et al. Antibodies to a synthetic peptide from the preS 120-145 region of the hepatitis B virus envelope are virus neutralizing. Vaccine 1986; 4: 35-37.
12. 12 Neurath AR, Kent SB, Strick N, Parker K. Identification and chemical synthesis of a host cell receptor binding site on hepatitis B virus. Cell 1986; 46: 429-436.
13. 13 Neurath R, Strick N, Kent S, Parker K, Seto B, Girard M. Design of synthetic peptides mimicking the immunologic and biologic functions of the preS1 sequence of the hepatitis B virus envelope protein. In: Ginsberg H, Brown F, Lerner RA, Chanack R, eds. Vaccines 88: New Chemical and Genetic Approaches to Vaccination: Prevention of AIDS and Other Viral, Bacterial and Parasitic Diseases. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1988: 229-234.
14. 14 Pontisso P, Petit MA, Bankowski MJ, Peeples ME. Human liver plasma membranes contain receptors for the hepatitis B virus pre-S1 region and, via polymerized human serum albumin, for the pre-S2 region. J Virol 1989; 63: 1981-1988.
15. 15 Thronton G, Moriarty A, Millich D, Eichberg J. Purcell R, Gerin J. Protection of chimpanzees from hepatitis B virus infection after immunization with synthetic peptides: identification of protective epitopes in the pre-S region. In: Lernen R, Ginsberg H, Chanack R, Brown F, eds. Vaccines 89: Modern Approaches to New Vaccines Including Prevention of AIDS. Cold Spring Harbor, New York: Cold Spring Harbor Laboratory Press, 1989: 467-472.
16. 16 Petit MA, Dubanchet S, Capel F, Voet P, Dauguet C, Hauser P. HepG2 cell binding activities of different hepatitis B virus isolates: inhibitory effect of anti-HBs and anti-preS1(21-47). Virology 1991; 180: 483-491.
17. 17 Petit MA, Strick N, Dubanchet S, Capel F, Neurath AR. Inhibitory activity of monoclonal antibody F35.25 on the interaction between hepatocytes (HepG2 cells) and preS1-specific ligands. Mol Imnmnol 1991; 28: 517-521.
18. 18 Neurath AR, Strick N. Antigenic mimicry of an immunoglobulin A epitope by a hepatitis B virus cell attachment site. Virology 1990; 178: 631-634.
19. 19 Pontisso P, Ruvoletto MG, Tiribelli C, Gerlich WH, Ruol A. Alberti A. The preS1 domain of hepatitis B virus and IgA cross-react in their binding to the hepatocyte surface. J Gen Virol 1992; 73: 2041-2045.
20. 20 Neurath AR, Strick N, Li YY. Cells transfected with human interleukin 6 cDNA acquire binding sites for the hepatitis B virus envelope protein. J Exp Med 1992; 176: 1561-1569.
21. 21 Neurath AR, Strick N, Sproul P. Search for hepatitis B virus cell receptors reveals binding sites for interleukin 6 on the virus envelope protein. J Exp Med 1992; 175: 461-469.
22. 22 Treichel U, Meyer zum Büschenfelde K, Gerken G. HBs antigen secretion by human hepatoma cells after binding and endocytosis of natural HBV particles via the asialoglycoprotein receptor. Hepatology 1993; 18 (suppl): 117A.
23. 23 Treichel U, Meyer zum Büschenfelde K, Gerken G. Hepatitis B virus infection in vitro mediated by endocytosis via the asialoglycoprotein receptor. J Hepatol 1993; 18 (suppl): S20.
24. 24 Petit MA, Capel F, Dubanchet S, Mabit H. PreS1-specific binding proteins as potential receptors for hepatitis B virus in human hepatocytes. Virology 1992; 187: 211-222.
25. 25 Duclos-Vallée JC, Mabit H, Capel F, Dubanchet S, Petit MA. Multiple enzyme activities of human liver glyceraldehyde-3-phosphate dehydrogenase (GAPD): involvement in early steps of the hepatitis virus (HBV) replication cycle. Hepatology 1995; 22 (suppl): 269A.
26. 26 Mehdi H. Kaplan MJ. Anlar FY et al. Hepatitis B virus surface antigen binds to apolipoprotein H. J Virol 1994; 68: 2415-2424.
27. 27 Mehdi H, Yang X, Peeples ME. An altered form of apolipoprotein H binds hepatitis B virus surface antigen most efficiently. Virology 1996; 217: 58-66.
28. 28 De Meyer S, Gong ZJ. Suwandhi W, van Pelt J, Soumillion A, Yap SH. Organ and species specificity of hepatitis B virus (HBV) infection: a review of literature with a special reference to preferential attachment of HBV to human hepatocytes. J Viral Hepat 1997; 4: 145-153.
29. 29 Leenders WP, Glansbeek HL. De Bruin WC. Yap SH. Binding of the major and large HBsAg to human hepatocytes and liver plasma membranes: putative external and internal receptors for infection and secretion of hepatitis B virus. Hepatology 1990; 12: 141-147.
30. 30 Hertogs K, Leenders WP, Depla E et al. Endonexin II, present on human liver plasma membranes, is a specific binding protein of small hepatitis B virus (HBV) envelope protein. Virology 1993; 197: 549-557.
31. 2 fragment of anti-human liver endonexin II immunoglobulin G: evidence for a receptor - ligand-like relationship between small hepatitis B surface antigen and endonexin II. J Virol 1994; 68: 1516-1521.
32. 32 de Bruin WC, Leenders WP, Moshage H, van Haelst UJ. Species specificity for HBsAg binding protein endonexin II. J Hepatol 1996; 24: 265-270.
33. 33 Gong ZJ, De Meyer S, van Pelt JF et al. Transfection of a rat hepatoma cell line with a construct expressing human liver Annexin V confers susceptibility to hepatitis B virus infection. Hepatology 1999; 29: 576-584.
34. 34 Haigler HT, Schlaepfer DD, Burgess WH. Characterization of lipocortin I and an immunologically unrelated 33-kDa protein as epidermal growth factor receptor/kinase substrates and phospholipase A2 inhibitors. J Biol Chem 1987; 262: 6921-6930.
35. 35 Rijntjes PJ, Moshage HJ, Yap SH. In vitro infection of primary cultures of cryopreserved adult human hepatocytes with hepatitis B virus. Virus Res 1988; 10: 95-109.
36. 36 Moshage HJ, Rijntjes PJ, Hafkenscheid JC, Roelofs HM, Yap SH. Primary culture of cryopreserved adult human hepatocytes on homologous extracellular matrix and the influence of monocytic products on albumin synthesis. J Hepatol 1988; 7: 34-44.
37. 37 Rijntjes PJ. Moshage HJ, Van Gemert PJ, De Waal R, Yap SH. Cryopreservation of adult human hepatocytes. The influence of deep freezing storage on the viability, cell seeding, survival, fine structures and albumin synthesis in primary cultures. J Hepatol 1986; 3: 7-18.
38. 38 Salacinski PR, McLean C, Sykes JE, Clement Jones VV, Lowry PJ. Iodination of proteins, glycoproteins, and peptides using a solid-phase oxidizing agent. 1,3,4,6-tetrachloro-3 alpha,6 alphadiphenyl glycoluril (Iodogen). Anal Biochem 1981; 117: 136-146.
39. 39 Diminsky D, Schirmbeck R, Reimann J. Barenholz Y. Comparison between hepatitis B surface antigen (HBsAg) particles derived from mammalian cells (CHO) and yeast cells (Hansenula polymorpha): composition, structure and immunogenicity. Vaccine 1997; 15: 637-647.
40. 40 Mabit H, Dubanchet S, Capel F, Dauguet C, Petit MA. In vitro infection of human hepatoma cells (HepG2) with hepatitis B virus (HBV): spontaneous selection of a stable HBV surface antigen-producing HepG2 cell line containing integrated HBV DNA sequences. J Gen Virol 1994; 75: 2681-2689.
41. 41 Chomczynski P, Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 1987; 162: 156-159.
42. 42 Kawasaki E. Amplification of RNA. In: Innis MA, Gelfand DH, Snisky JJ, White TJ, eds. PCR Protocols: a Guide to Method and Applications. San Diego: Academic Press, 1990: 21-27.
43. 43 Sallie R. Selective detection of hepatitis B virus RNA by PCR. PCR Methods Appl 1994; 3: 376-377.
44. 44 Köck J. Theilmann L, Galle P, Schlicht HJ. Hepatitis B virus nucleic acids associated with human peripheral blood mononuclear cells do not originate from replicating virus. Hepatology 1996; 23: 405-413.
45. 45 Gong ZJ. De Meyer S, Roskams T et al. Hepatitis B virus infection in microcarrier-attached immortalized human hepatocytes cultured in molecularporous membrane bags: a model for long-term episomal replication of HBV. J Viral Hepat 1998; 5: 377-387.
46. 46 Sells MA, Chen ML, Acs G. Production of hepatitis B virus particles in Hep G2 cells transfected with cloned hepatitis B virus DNA. Proc Natl Acad Sci USA 1987; 84: 1005-1009.
47. 47 MacNab GM, Alexander JJ. Lecatsas G, Bey EM, Urbanowicz JM. Hepatitis B surface antigen produced by a human hepatoma cell line. Br J Cancer 1976; 34: 509-515.
48. 48 Chakraborty PR, Ruiz-Opazo N. Shouval D, Shafritz DA. Identification of integrated hepatitis B virus DNA and expression of viral RNA in an HBsAg-producing human hepatocellular carcinoma cell line. Nature 1980; 286: 531-533.
49. 49 Gong ZJ, De Meyer S, Clarysse C et al Mycophenolic acid, an immunosuppressive agent, inhibits HBV replication in vitro, J Viral Hepat 1999; 6: 229-236.
50. 50 Southern EM. Detection of specific sequences among DNA fragments separated by gel electrophoresis. J Mol Biol 1975; 98: 503-517.
51. 51 Manzin A, Salvoni G, Bagnarelli P, Menzo S, Carloni G, Clementi M. A single-step DNA extraction procedure for the detection of serum hepatitis B virus sequences by the polymerase chain reaction. J Virol Methods 1991; 32: 245-253.
52. 52 Yap SH, Willems M, Van den Oord J et al. Detection of hepatitis C virus antigen by immuno-histochemical staining: a histological marker of hepatitis C virus infection. J Hepatol 1994; 20: 275-281.
53. 53 Karpen S, Banerjee R, Zelent A, Price P, Acs G. Identification of protein-binding sites in the hepatitis B virus enhancer and core promoter domains. Mol Cell Biol 1988; 8: 5159-5165.
54. 54 Ben-Levy R, Faktor O, Berger I, Shaul Y. Cellular factors that interact with the hepatitis B virus enhancer. Mol Cell Biol 1989; 9: 1804-1809.
55. 55 Yaginuma K, Koike K. Identification of a promoter region for 3.6-kilobase mRNA of hepatitis B virus and specific cellular binding protein. J Virol 1989; 63: 2914-2920.
56. 56 Wright JF, Kurosky A, Pryzdial ELG, Wasi S. Host cellular Annexin II is associated with cytomegalovirus particles isolated from cultured human fibroblasts. J Virol 1995; 69: 4784-4791.
57. 57 Huang RTC, Lichtenberg B, Rick O. Involvement of annexin V in the entry of influenza viruses and role of phospholipids in infection. FEBS Lett 1996; 392: 59-62.